Dr. Triplett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl
Memphis, TN 38105Phone+1 888-226-4343
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2003 - 2006
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 2000 - 2003- Saint Louis University School of MedicineClass of 2000
Certifications & Licensure
TN State Medical License 2004 - 2026- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies Start of enrollment: 2007 Dec 14
- Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy Start of enrollment: 2013 May 16
- Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation Start of enrollment: 2014 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 142 citationsLentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.Ewelina Mamcarz, Sheng Zhou, Timothy D. Lockey, Hossam Abdelsamed, Shane J Cross
The New England Journal of Medicine. 2019-04-17 - 38 citationsNatural killer cell therapy in children with relapsed leukemiaJeffrey E. Rubnitz, Hiroto Inaba, Guolian Kang, Kwan Gan, Christine Hartford
Pediatric Blood & Cancer. 2015-08-01 - 106 citationsHuman memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasisHossam A. Abdelsamed, Ardiana Moustaki, Yiping Fan, Pranay Dogra, Hazem E. Ghoneim
The Journal of Experimental Medicine. 2017-06-05
Journal Articles
- Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell DepletionBrandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
